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Abstract
Background: Norcantharidin, the demethylated analog of cantharidin derived from a traditional Chinese medicine,
Mylabris, has been used in the treatment of anti-cancer effects. However, the detailed mechanisms underlying this
process are generally unclear. The aim of this study was to investigate the mechanism of NCTD-induced apoptosis
in HepG2 cells.
Methods: The cytotoxicity was measured by MTT assay for cellular viability and by flow cytometry. The
mitochondrial membrane potential and reactive oxygen species production was evaluated by flow cytometry
analysis. The role of caspase activities were assayed using caspase apoptosis detection kit . Western blot analysis
was used to evaluate the level of Cyto-C, Bcl-2, Bax, Bid, caspase 3, -9, -8 and PARP expression
Results: After treatment with NCTD, a decrease in the viability of HepG2 cells and increase in apoptosis were
observed. NCTD-induced apoptosis was accompanied by an increase in ROS production, loss of mitochondrial
membrane potential and release of cytochrome c(cyto-c) from the mitochondria to the cytosol and down-
regulation of anti-apoptotic protein Bcl-2 levels with concurrent up-regulation in pro-apoptotic protein Bax levels.
However, another pro-apoptotic molecule, Bid, showed no change in such same treatment. NCTD-increased
activity of caspase 9,caspase 3 and the subsequent cleavage caspase substrate PARP were also observed. The
expression levels of pro-caspase-8 were not changed after NCTD treatment.
Conclusion: These results indicate that NCTD induced cytotoxicity in HepG2 cells by apoptosis, which is mediated
through ROS generation and mitochondrial pathway.
Background
Hepatoma is the sixth most common cancer worldwide.
Its incidence increased rapidly and becomes the leading
cause of cancer-related deaths in the world [1]. To date,
chemotherapy has been the most frequently used treat-
ment for liver cancer and other cancers. However, The
toxicity of these chemotherapy medicines to normal tis-
sues and normal cells has been one of the major obsta-
cles to successful cancer chemotherapy. Obviously, there
is an urgent need to identify new therapeutic agents for
the treatment of hepatoma. Norcantharidin (NCTD) is
the demethylated analog of cantharidin isolated from
natural blister beetles. In China, NCTD has been used
in traditional Chinese medicine for more than two thou-
sand years. Currently it is used as an anticancer drug to
treat breast cancer, lung cancer, leukemia, colon cancer,
etc [2-6]. However, the signaling pathways governing
apoptosis in human HepG2 cells remains unclear.
Apoptosis is an important phenomenon in cytotoxicity
induced by anticancer drugs. The execution of apoptosis,
or programmed cell death [7], is associated with charac-
teristic morphological and biochemical changes mediated
by a series of gene regulation and cell-signaling pathways.
Recently, perturbation of mitochondrial function has
been shown to be a key event in the apoptotic cascade
[8]. Anticancer drugs may damage the mitochondria by
increasing the permeability of the outer mitochondrial
membrane, which is associated with the collapse of the
mitochondrial membrane potential (Δm), because a
decline in Δm can disturb intracellular ATP synthesis,
generation of reactive oxygen species (ROS), altered
mitochondrial redox ratio, translocation of cyto c to
the cytosol, and degradation of caspase-3/PARP [9-12].
In this regard, we have initiated experiments aimed at
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human HepG2 cells, a rapidly proliferating and malignant
cell line.
Materials and methods
Chemicals and Reagents
NCTD of analytical grade purity were purchased from
Sigma Chemical Co.( St. Louis, USA); a stock solution
(5 mg/ml) in RPMI1640(HyClone, USA) was prepared and
stored at 4°C. D-Hanks’ solution, penicillin, streptomycin,
fetal bovine serum, and EDTA,3-[4,5-Dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium bromide (MTT), propidium
iodide in this study were purchased from Sigma Chemical
C o ( S t .L o u i s ,U S A ) .A n t i - r a b b i tB c l - 2 ,B i d ,B a x ,c y t o -
chrome c, and b-actin antibodies and HRP-conjugated
goat anti-rabbit Ig were from R&D Systems Inc (Minnea-
polis, USA) . Anti-caspase-3, -8, -9 and anti-PARP were
purchased from blue sky Chemical Co, LTD (Nantong,
China). Dichlorodihydrofluorescein diacetate (DCHF-DA),
N-acetyl-L-cysteine (NAC) and JC-1 kit were purchased
from keygen Biotechnology Co., LTD(Nanjing, China).
Caspase apoptosis detection kit and Annexin V-FITC kit
were obtained from Beijing Biosea Biotechnology Co, LTD
(Beijing, China).
Cell Line and Cell Culture
The human hepatoma cell lines HepG2 was obtained
from department of oncology, Zhongnan Hospital of
Wuhan University (Wuhan, China), cells were cultivated
in 5% CO2 at 37°C in RPMI1640 medium supplemented
with 10% heat-inactivated fetal bovine serum, glutamine
(2 mmol/L), and antibiotics (100 U/ml penicillin,
100 mg/ml streptomycin).
Cell Viability Assay
The inhibition of cell proliferation by NCTD was deter-
m i n e db ya s s a y i n gt h er e d u c tion of MTT to formazan.
After incubation with NCTD for 24, 36 and 48 h, the
cells(10
4/well) in 96-well plates were washed twice with
phosphate-buffered saline (PBS), and MTT (100 μg/0.1
mL of PBS) was added to each well. The cells were incu-
bated at 37°C for 4 h, and DMSO (100 μL) was added to
dissolve the formazan crystals. The absorbance rate of
each well optical density (OD value) was measured at 570
nm by a spectrophotometer. The cell proliferation inhibi-
tion rate was calculated as 1-(average OD value of wells
with administered drug/average OD value of control
wells)×100. To explore the possibility that NCTD
induced intracellular ROS in antiproliferation, the
HepG2 cells were pretreated with NAC (10 mM) 2 h
before treatment with NCTD, followed by NCTD
(5,10,20,40 μg/ml) treatment for 24 h. HepG2 cells prolif-
eration response was determined by MTT assay as
described above. The experiments and all the below
assays were repeated thrice.
Annexin V/PI Staining Assay
To quantify the percentage of cells undergoing apopto-
sis, we used Annexin V-FITC kit. HepG2 cells were
incubated for 24 h with NCTD (10,20,40 μg/ml). Then
the cells were washed twice with cold PBS and resus-
pended in binding buffer at a concentration of 1 × 10
6
cells/ml. After incubation, 100 μlo ft h es o l u t i o nw a s
transferred to a 5 ml culture tube, and 5 μlo fA n n e x i n
V-FITC and 10 μlo fP Iw e r ea d d e d .T h et u b ew a s
gently vortexed and incubated for 15 minutes at room
temperature in the dark. At the end of incubation, 400
μl of binding buffer was added, and the cells were ana-
lyzed immediately by flow cytometry. Flow cytometry
analysis was performed using the Cell Quest software.
Analysis of ROS production
The intracellular ROS level was detected by flow cyto-
metry using DCHF-DA.
DCHF-DA is a stable fluorescent ROS-sensitive com-
pound, which readily diffuses into cells. DCHF-DA is
hydrolyzed by esterase to form DCHF within cells,
which is oxidized by hydrogen peroxide or low-molecu-
lar-weight peroxides to produce the fluorescent com-
pound 2’,7’-dichlorofluorescein(DCF). In the present
study, HepG2 cells were treated with NCTD (10, 20, 40
μg/ml) for 6 h, followed by staining with DCHF-DA
(100 μM) for an additional 30 min. Green fluorescence
in cells under different treatments was analyzed by flow
cytometry analysis. NAC(10 mM) was added 1 h prior
to the treatment with 20 μg/ml NCTD for 6 h.
Measurement of Mitochondrial Membrane Potential(Δm)
The loss of Δm was monitored with the dye JC-1. JC-1 is
capable of selectively entering mitochondria, where it
f o r m sm o n o m e r sa n de m i t sg reen fluorescence when
Δm is relatively low. At a high Δm, JC-1 aggregates and
gives red fluorescence. The ratio between green and red
fluorescence provides an estimate of Δm that is indepen-
dent of the mitochondrial mass. Briefly, HepG2 cells (1 ×
10
6 cells/ml) in 10-cm culture dishes were treated without
or with NCTD (10,20,40 μg/ml) for 24 h. Cells were tryp-
sinized, washed in ice-cold PBS, and incubated with 10
mM JC-1 at 37°C for 20 min in darkness. Subsequently,
cells were washed twice withP B Sa n da n a l y z e db yf l o w
cytometry. Excitation wave was set at 488 nm and the
emitted green fluorescence of Annexin V-FITC (FL1) and
red fluorescence of PI (FL2) were collected using 525 and
575 nm band pass filters, respectively.
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Mitochondria to the Cytosol
Cytochrome c determination in cytosolic and mitochon-
drial fractions was done by western blotting. The cells
were harvested without or with NCTD (10,20,40 μg/ml)
for 24 h and then washed once with ice-cold PBS. For
isolation of mitochondria and cytosol, the cells were
sonicated in buffer containing 10 mM Tris-HCl pH 7.5,
10 mM NaCl, 175 mM sucrose, and 12.5 mM EDTA
and the cell extract centrifuged at 1000 g for 10 min to
pellet nuclei. The supernatant thus obtained was centri-
fuged at 18000 g for 30 min to pellet the mitochondria
and purified as previously described. The resulting
supernatant was termed the cytosolic fraction. The pel-
let was lysed and protein content estimated in both frac-
tions by Bradford’s method. Equal amounts of protein
were separated on 15% sodium dodecyl sulfate-polyacry-
lamide gel electrophoresis (SDS-PAGE) then were elec-
trotransferred to polyvinylidene difluoride (PVDF)
membrane. The membrane was then incubated in 5%
non-fat milk in TBST (TBS: Tris-buffered-saline,
10 mM Tris, 150 mM NaCl, pH 7.6 with 0.1% Tween
20) for 2 h followed by overnight incubation with the
primary antibody separately. The incubated membranes
were extensively washed with TBST before incubation
for 2 h with the secondary anti-body. After extensive
washing with TBST, the immune complexes were
detected by enhanced chemiluminescence detection kit.
Caspase activity assay
Analysis of caspase-3, and caspase-9 activities was per-
formed using Caspase Apoptosis Detection Kit accord-
ing to the manufacturer’s instruction. In brief, after
treatment with NCTD (10,20,40 μg/ml) for 24 h, cells
(1 × 10
6) were pelleted by centrifugation, washed with
PBS two times and incubated in 500 μL lysis buffer on
ice for 10 min, then 1 × reaction buffer and 10 μLc a s -
pase-3( DEVD-AFC), caspase-9 (IEVD-AFC)substrates
w a sa d d e dt ol y s i sb u f f e r .T h e reaction mixtures were
incubated at 37°C for 60 min. Activities of caspase-3
and -9 were measured by spectrofluorometry.
Western blot analysis
To detect the effects of NCTD on protein expressions,
we used the Western blot analysis as described in the
method of Sang-Heng Kok et al [13]. After treatment
with NCTD (10,20,40 μg/ml) for 24 h, the floating and
adherent cells were harvested and lysed in lysis buffer
(20 mM Tris-HCl at pH 7.4, 150 mM NaCl, 0.5% NP-
4 0 ,1m ME D T A ,5 0μg/ml leupeptin, 30 μg/ml aproti-
nin, 1 mM phenylmethylsulfonyl fluoride, PMSF). Cell
lysates were then clarified by microcentrifugation at
12,000 g for 10 min at 4 °C. Aliquots (30 μg) of the cel-
lular lysates were subjected to 12.5% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto a nitrocellulose membrane (Amer-
sham Biosciences, UK). The membrane was then probed
with primary antibodies to Bcl-2, Bax, Bid, cytochrome
c, caspase-3, -8, -9, PARP and b-actin overnight, fol-
lowed by the addition of goat anti-mouse or anti-rabbit
horseradish peroxidase-link secondary antibodies. After
washing, the ECL chemical reagents were added to the
membrane and chemilluminescence was visualized using
an enhanced chemiluminescence detection kit (Amer-
sham, Aylesbury, UK). b-actin was used as internal con-
trol to confirm that the amounts of protein were equal.
Statistical analysis
Data were expressed as means ± SD and analyzed using
SPSS 13.0 software. Differences between the groups
were evaluated by the t-test and inter-group differences
were evaluated by a one-way ANOVA. P <0 . 0 5w e r e
considered statistically significant
Result
Proliferation inhibitory effect of NCTD
The inhibition of proliferation by NCTD in the human
hepatoma cell HepG2 cell line was assessed after 24, 36,
48 h of drug exposure, following 24 h culture in drug-free
medium. As shown in Figure 1, after treatment with
NCTD, the growth inhibitory effect of NCTD at low con-
centrations(2.5 μg/ml) on HepG2 cells was not obvious;
but as concentration increased, proliferation of HepG2
cells was markedly inhibited by NCTD in dose- and time-
dependent manners at the concentrations of 5-40 μg/ml
for 24, 36 and 48 h, respectively in vitro (P < 0.05).
To explore the possibility that NCTD induced intracel-
lular ROS in antiproliferation, the HepG2 cells were pre-
treated with NAC(10 mM) 2 h before treatment with
NCTD (5,10,20,40 μg/ml) for 24 h. As shown in Figure 2
Figure 1 Proliferation inhibitory effect of NCTD. Cells were
incubated with different concentrations of NCTD for 24, 36, 48 h,
followed by MTT assay. As shown in Fig.1, NCTD inhibits the
proliferation and cell viability of HepG2 cells in a dose-and-time
dependent manner.
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NCTD+NAC groups(P < 0.05)
Flow cytometric estimation of NCTD induced apoptosis
Exposure of phosphotidyl serine on the surface of cells is
an early event in the onset of apoptosis, which has strong
binding affinity for AnnexinV in the presence of calcium
HepG2 cells were incubated with differen concentration
of NCTD and cells were stained with AnnexinV-FITC
and PI to assess the apoptotic and necrotic cell popula-
tion (Figure 3A). NCTD produced dose-dependant
increase in the apoptotic cell population. The basal apop-
totic population in the untreated culture was 0.3 ± 0.1%.
After treatment with NCTD (10, 20, 40 μg/ml) for 24 h,
the apoptotic rate raised to 18.23 ± 1.19%, 32.5 ± 2.30%,
48.23 ± 1.17% (Figure 3B), respectively.
Generation of ROS in HepG2 cells treated with NCTD
ROS generation was analyzed by flow cytometry. Cells
were treatment with variousc o n c e n t r a t i o n so fN C T D
(10, 20, 40 μg/ml) for 24 h, and then DCF fluorescence
was recorded as a measure of intracellular ROS. As
shown in Figure 4A, the treatment of HepG2 cells with
NCTD resulted in a dose-dependent increase in ROS
generation. As shown in Figure 4B, the result demon-
strated that the NAC pretreated cells reduced levels of
FL-1 fluorescence of DCF.
Mitochondria Membrane Potential (Δm) Determination
Disruption of mitochondrial integrity is one of the early
events leading to apoptosis. To assess whether NCTD
affects the function of mitochondria, potential changes in
mitochondrial membrane were analyzed by employing a
mitochondria fluorescent dye, JC-1. As shown in Figure 5,
exposure to NCTD for 24 h resulted in a significant
decrease in the ratio between red and green fluorescence
by approximately 33.83 ± 1.53%, 45.23 ± 0.78%, and 56.6 ±
0.85% at 10, 20 and 40 μg/ml, respectively. This suggests
that treatment with various concentrations of NCTD (10,
20, 40 μg/ml) for 24 h resulted in significant decreases of
Δm. The results imply that NCTD induces Δm dissipa-
tion in a concentration-dependent manner.
Cytochrome c Release from Mitochondria to Cytosol
Cytochrome c release from mitochondria is a critical
step in the apoptotic cascade since this activates down-
stream caspases. To investigate the release of cyto-
chrome c in NCTD-treated HepG2 cells, we conducted
western blotting in both the cytosolic and mitochondrial
fractions. The results demonstrate a concentration-
dependent increase in the cytosolic cytochrome c after
treatment with NCTD. Simultaneously, there was a
decrease in cytochrome c in the mitochondrial fraction
(Figure 6A).
Roles of members of the Bcl-2 family protein in NCTD-
induced apoptosis
Since translocation of Bcl-2 families fromthe cytosol to
the mitochondria is known to play a key role in mito-
chondrial-mediated apoptosis induced by a variety of
apoptotic stimuli, we investigated the altered expression
levels of the members of Bcl-2 family proteins such as,
Bcl-2, Bax and Bid. We observed that the expression of
pro-apoptotic Bax was increased in the mitochondrial
fraction (Figure 6A). However, another pro-apoptotic
m o l e c u l e ,B i d ,s h o w e dn oc h a n g ei ns u c hs a m et r e a t -
ment. Conversely, the anti-apoptotic protein Bcl-2 was
decreased in a dose-dependent manner (Figure 6A).
These results suggest that NCTD might induce apopto-
sis through Bcl-2/Bax, but not Bid, -mediated mitochon-
drial dysfunction pathway
Activation of caspase-9/caspase -3, PARP, but not
caspase-8, is involved in NCTD-induced apoptosis
Since caspases are known to play a central role in mediat-
ing various apoptotic responses, we investigated which
caspases are involved in NCTD-induced apoptosis of
HepG2 cells. We first examined whether NCTD affects
the activation of pro-caspase-8 in HepG2 cells. The
expression levels of pro-caspase-8 were not changed after
NCTD treatment (Figure 6B). We observed that the pro-
cessing of pro-caspase-9 to active caspase-9 was increased
by the treatment of NCTD in a dose-dependent manner
(Table 1 & Figure 6B). We also found that NCTD signifi-
cantly increased the cleavage of pro-caspase-3 to the active
form in a dose-dependent manner (Table 1 & Figure 6B).
Subsequently, the presence of activated caspase-3
is further confirmed by detecting the degradation of
PARP, a DNA repair enzyme, which undergoes cleavage
Figure 2 Effect of NCTD and NCTD+NAC on HepG2 cell growth.
To explore the possibility that NCTD induced intracellular ROS in
antiproliferation, the HepG2 cells were pretreated with NAC (10
mM) 2 h before treatment with NCTD, followed by NCTD (5,10,20,40
μg/ml) treatment for 24 h.
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cleavage of PARP also occurred in a dose-dependent man-
ner (Figure 6B).We could confirm that caspase-3 activity
was also increased in a dose-dependentmanner (Figure
6B). These results suggest that NCTD -induced apoptosis
is associated with the activation of caspase-9 caspase-3
and PARP but not with caspase-8.
Discussion
Hepatoma remains a major public health threat and the
third most common cause of death from cancer. To
date, chemotherapy and radiotherapy are the most fre-
quently used palliative treatment for liver and other can-
cers. However, some normal cells are destroyed as well
by this method of treatment . Therefore to find novel
natural compounds with low toxicity and high selectivity
of killing cancer cells is an important area in cancer
research. Due to the wide range of biological activities
and low toxicity in animal models, some natural pro-
ducts have been used as alternative treatments for can-
cers including liver cancer.
The Chinese herb Norcantharidin (NCTD) has been
used in traditional Chinese medicine for more than two
thousand years. The first recorded use of cantharidin as
an anti-cancer agent was in 1264 [2]. Currently, multiple
studies in vitro and in vivo have shown that NCTD was
cytotoxic to various types of tumor cells .The significant
apoptotic effects was also observed in tumor cells trea-
ted by NCTD.
Apoptosis can be initiated via two alternative signaling
pathways: the death receptor-mediated extrinsic apopto-
tic pathway and the mitochondrion-mediated intrinsic
apoptotic pathway [13-15]. Mitochondria play critical
roles in the regulation of various apoptotic processes
including drug-induced apoptosis [16].The mitochondrial
death pathway is controlled by members of the Bcl-2
family, which play a central regulatory role to decide the
fate of the cells via the interaction between pro- and anti-
apoptotic members [17,18].The Bcl-2 family consists of
pro-apoptotic and anti-apoptotic members [19].During
apoptosis, Bcl-2 family pro-apoptotic proteins including
Bim, Bax and Bid can translocate to the outer membrane
Figure 3 Apoptosis Induced by NCTD. (A) HepG2 cells were treated without or with NCTD (10,20,40 μg/ml) for 24 h, then processed for
Annexin V/PI staining and analyzed by flow cytometry. Annexin V-positive/PI-negative cells are in early stages of apoptosis and double positive
cells are in late apoptosis (B) *P < 0.05 vs Control,
#P < 0.01 vs Control,
▲P < 0.05 vs 10 μg/ml NCTD,
※P < 0.05 vs 20 μg/ml NCTD.
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factors, and induce apoptosis. On the other hand, Bcl-2
family anti-apoptotic proteins including Bcl-2 and Bcl-
XL, sequestered in mitochondria, inhibit the release of
pro-apoptotic factors and prevent apoptosis. When inter-
acting with activated pro-apoptotic proteins, the anti-
apoptotic proteins lose inhibiting ability of pro-apoptotic
factors’ release, and again promote apoptosis. Alteration
in the levels of anti- and pro-apoptotic Bcl-2 family pro-
teins influences apoptosis [20]. In this study, the NCTD-
induced apoptosis in HepG2 cells was accompanied by
up-regulation of Bax and the down-regulation of Bcl-2,
suggesting that NCTD induced apoptosis in HepG2 cells
by modulating Bcl-2 family proteins.
Recent data indicate that caspases play a key role in the
initiation of apoptosis [21,22]. In the present study, NCTD
treatment caused the activation of caspase-3 and -9 in a
dose-dependant manner that is consistent with the results
of PARP activation and cell apoptosis. These results
demonstrated that NCTD-induced apoptosis may involve
a caspase-3-mediated mechanism and activation of
caspase-9 may act upstream of caspase-3 activation. Mito-
chondria have been reported to play a critical role in the
regulation of apoptosis [23,24]. Consistent with these
results, in the cytosol of NCTD -treated HepG2 cells, cyto
c was detected after a 24 h treatment period. Once
released into the cytosol, cyto c binds with procaspase-9 in
the presence of ATP and Apaf-1 to form the apoptosome.
This complex activated caspase-9, which, in turn, cleaves,
and thereby activates, caspase-3. In NCTD-treated cells,
the release of cyto c from the mitochondria was followed
by activation of caspase-9 and caspase-3. It has been
reported that the release of cyto c appears to be dependent
on the induction of mitochondrial permeability transition,
Figure 4 Effect of NCTD on ROS generation in HepG2 cells. (A) Cells were treated with NCTD for 6 h, followed by staining with DCHF-DA
(100 μM) for an additional 30 min. NAC(10 mM) was added 1 h prior to the treatment with 20 μg/ml NCTD for 6 h.Cells treated with NCTD
showed a dose-dependent increase in ROS generation. The horizontal axis represents DCFH-DA fluorescence and the vertical axis represents cell
count. (B) *P < 0.01 vs Control,
§P < 0.05 vs 10 μg/ml NCTD,
▲P < 0.05 vs 20 μg/ml NCTD,
#P < 0.01 vs 20 μg/ml NCTD.
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indicated. Change in Δm was determined by flow cytometric analysis with JC-1. (B) *P < 0.01 vs Control,
§P < 0.01 vs 10 μg/ml NCTD,
▲P<
0.01 vs 20 μg/ml NCTD .
Figure 6 Effect of NCTD on Expression of Cyto-C, Bax/Bcl-2/Bid, caspase-3/-8/-9 and PARP proteins in HepG2 Cells. Cells were treated
with increasing doses of NCTD for 24 h. Equal amounts of whole cell extracts were fractionated by SDS-PAGE and protein were detected by
Western blot analysis. (A) Cyto-c, Bax, Bcl-2, Bid (B) Caspase 3, -9, -8, PARP.
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loss of Δm and the release of apoptogenic factors, such
as cyto c, from the mitochondria into the cytosol are asso-
ciated with apoptosis induced by chemotherapeutic drugs
[25-27]. In the present study, loss of Δma n dr e l e a s eo f
Cyto c were observed in NCTD-treated cells, resulting in
caspase-9 and caspase-3 activation and PARP cleavage
and, finally, apoptosis. Moreover, the loss of Δm may, in
fact, be a consequence of massive cytochrome c release
from the mitochondria. Thus, a mitochondrial damage-
dependent pathway may be involved in NCTD-induced
apoptosis in HepG2 cells.
Some studies have reported that ROS act as secondary
messengers in apoptosis induced by anti-cancer and
chemopreventive agents [28,29]. The generation of ROS
can cause the loss of Δm, and induce apoptosis by
releasing pro-apoptotic proteins such as AIF and Cyto c
from mitochondria to the cytosol .The generation of
ROS may contribute to mitochondrial damage and lead
to cell death by acting as an apoptotic signaling mole-
cule [30,31]. To reveal if NCTD influenced the level of
Table 1 Effects of NCTD on the activation of caspase-3, -9
Caspase 3 Caspase 9
Control 10.07 ± 1.13 36.32 ± 4.39
10 μg/ml 18.76 ± 1.22* 48.87 ± 1.72*
20 μg/ml 35.71 ± 2.83** 53.89 ± 2.54**
40 μg/ml 37.32 ± 1.28** 55.92 ± 3.16**
*P < 0.05 vs Control **P < 0.01 vs Control.
Figure 7 A proposed model showing the mechanism of NCTD anti-proliferative and apoptosis effects in HepG2 cells.R O S ,r e a c t i v e
oxygen species; PARP, poly (ADP ribose)polymerase; Δm, mitochondrial membrane potential; Apaf-1, apoptotic protease activating factor-1.
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found that, in addition to its effect on Δm, NCTD
caused an increase in ROS production in HepG2 cells.
The NCTD -induced increase in ROS and antiprolifera-
tion in HepG2 cells are apparently dependent on ROS
generation, because the NCTD -induced increase in
ROS can be
abolished or attenuated by antioxidants, such as NAC.
In addition, we found that NCTD -induced antiproli-
feration in HepG2 cells was also abolished by the anti-
oxidant NAC.
Conclusions
In conclusion, our data indicate that NCTD induced
apoptosis in HepG2 cells via ROS generation and mito-
chondrial pathway (Figure 7) [32]. These findings sug-
gest that NCTD may one day be used in the prevention
and treatment of cancer.
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